Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault'

The FDA logo seen on the mid-level facade of its office building in Maryland. (Credit: Reuters)

The US Food and Drug Administration (FDA) has issued its highest-level recall on more than two million Dexcom Continuous Glucose Monitoring (CGM) devices, warning diabetic patients and healthcare providers of a critical safety fault that could pose life-threatening risks.

Dexcom, a leading manufacturer of CGM devices widely used by people with diabetes to monitor blood sugar levels in real-time, has been forced to recall specific models of its G6 CGM system. The FDA's Class I recall designation signals a potential for serious injury or death associated with the fault.